Join for free and get access to the buyside
Get insights from the world's most influential hedge fund investors direct to your inbox
- © 2025 Buyside Digest
- Privacy Policy
- Disclaimer
- Sitemap
- Terms of Service
| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Keywords/Themes | Theme Commentary | Pitches | Letter |
|---|---|---|---|---|---|---|---|---|---|
| 2025 Q4 | Jan 30, 2026 | Staude Capital – The Global Value Fund | - | - | AA4.L, DNA2.L, DNA3.L, ESP.L, HVPE.L, UTG.L | AI, earnings, global, inflation, Trade Policy, Valuations, value | US share markets are trading nearly as expensively as they ever have relative to history. The manager presents extensive analysis showing strong negative correlation between high valuations and future 10-year returns, with current forward P/E of 25.6 suggesting poor long-term prospects. Even using 3-year forward earnings estimates, markets still appear fully valued with limited upside potential. Artificial Intelligence continues to drive investor excitement and market performance. US company earnings are forecast to grow by 44% over the next three years, driven largely by expectations for AI companies to deliver on their lofty targets. The manager acknowledges AI as a key driver but questions whether even exceptional earnings growth can justify current valuations. Early studies show that approximately 90% of tariff costs are being borne by US consumers and companies, contrary to Trump administration narratives. Tariffs added 0.7% to US inflation in 2025, making typical households $600 poorer. The manager views this as a longer-term headwind to the US economy and questions the real negotiating leverage tariffs provide. The manager positions as a value investor focused on building a portfolio where they generate returns by actively unlocking value within holdings rather than relying on market movements. They do not own many assets that investors are most excited about currently, preferring to focus on discount capture strategies and undervalued opportunities. | View | |
| 2025 Q4 | Jan 23, 2026 | WS AVI Worldwide Opportunities Fund | 2.9% | 10.8% | AERI.L, BSIF.L, BSRT.L, CGEO.L, CHRY.L, GABI.L, GCP.L, GRID.L, HVPE.L, PIN.L, RMII.L, RNEW.L, USF.L, VH.L | Capital Allocation, Discount Arbitrage, Energy Storage, Investment Trusts, private equity, Renewables, Uk, Value Investing | GRID is the largest owner of operational battery storage projects in the UK with over 1GW of capacity and substantial pipeline. Additional tolling agreements and long-term refinancing enable CAPEX programme for augmentation and new capacity. Expected to generate material free cash flow for buybacks or dividends. Discounts for funds of funds are still far too wide and persistently so. Stark arbitrage available from selling underlying third-party fund interests at tight discounts in secondary market to fund share buybacks at much wider discounts. HVPE announced $300m sale at 6% discount to fund debt repayment and buybacks. Multiple renewable-focused investment companies were detractors due to depressed sentiment towards UK renewables and government consultation on ROCs and FiTs modifications. Several funds in managed run-off processes experiencing generation shortfalls and challenging asset sale environments. Georgia Capital demonstrates best-in-class capital allocation with no new investments while discount remains wide and proceeds from divestments used to fund share buybacks. This approach is highlighted as a key investment thesis driver. | GABI LN BSRT LN GRID LN CGEO LN |
View |
| 2025 Q4 | Jan 20, 2026 | OAM European Value Fund | - | - | 096770.KS, BSRT.L, DAN.MI, HANA.L, HAUTO.OL, HVPE.L, NN.AS, NRO.PA, OCI.L, PIN.L, RCP.L, RTW.L, SBER.ME, SIBN.ME, STAN.L, VIG.VI, WALW.OL, WWI.OL, YAR.OL | Biotechnology, Discounts, Europe, insurance, NAV, private equity, shipping, value | Fund focuses on buying shares in decent operating businesses at significant discounts to intrinsic value. European value stocks had their largest outperformance versus growth stocks in 30 years, beating them by 19 percentage points in 2025. Manager believes value will continue to outperform growth during remainder of this decade. Major holdings include NN Group (Dutch life and non-life insurance) and Vienna Insurance Group (leading in Central and Eastern Europe). VIG was best performing stock with 158% return, benefiting from acquisition of Nürnberger and expansion opportunities in Eastern European markets with low insurance penetration rates. Fund had exceptional exposure to car carrier industry through Wallenius Wilhelmsen, Höegh Autoliners, and Wilhelmsen family holding company. Generated 110% IRR over 5 years before exiting operating companies due to expected decline in freight rates as new supply enters market. New investment in RTW Biotech reflects belief that gene splicing and editing will be the next big thing over coming generation. Biotech emerging from bear market with increased M&A activity as Big Pharma faces patent cliff. RTW positioned globally including China's rapidly growing biotech sector. Fund invests in listed private equity funds trading at significant discounts to NAV. Holdings include Pantheon International and HarbourVest Global Private Equity at 26% discounts versus typical 10% discounts in secondaries market. M&A activity picking up, underscoring valuations. | RTW LN DAN IM VIG AV STAN LN |
View |
| Date | Pitch Type | Author | Company | Industry | Sub Industry | Bull / Bear | Stock Exchange | Keywords | Action |
|---|---|---|---|---|---|---|---|---|---|
| No pitches found. | |||||||||
| Manager Name | Fund Name | Fund AUM | Invested Value | Portfolio Weight | Shares Owned | Shares Bought / Sold During Quarter | % Bought / Sold During Quarter | % of Shares Outstanding Owned |
|---|---|---|---|---|---|---|---|---|
| No investor data available. | ||||||||